220 related articles for article (PubMed ID: 8668605)
1. Evolving role of calcium channel blockers in heart failure.
Pieper JA
Pharmacotherapy; 1996; 16(2 Pt 2):43S-49S. PubMed ID: 8668605
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure.
Packer M
Circulation; 1989 Dec; 80(6 Suppl):IV59-67. PubMed ID: 2688986
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
Heywood JT
Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
[TBL] [Abstract][Full Text] [Related]
4. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.
Packer M; Kessler PD; Lee WH
Circulation; 1987 Jun; 75(6 Pt 2):V56-64. PubMed ID: 3552317
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
White CM
Conn Med; 1997 Oct; 61(10):659-61. PubMed ID: 9375452
[No Abstract] [Full Text] [Related]
6. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
Hilleman DE
Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
[TBL] [Abstract][Full Text] [Related]
7. [Calcium channel blockers in heart failure].
Hole T; Dickstein K; Gundersen T; Kjekshus J; Myhre ES; Rønnevik PK; Westheim AS
Tidsskr Nor Laegeforen; 1997 Jun; 117(16):2329-32. PubMed ID: 9265278
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of heart failure with calcium antagonists].
Hall D; Dirschinger J; Kraus F; Rudolph W
Herz; 1990 Jun; 15(3):179-84. PubMed ID: 2198218
[TBL] [Abstract][Full Text] [Related]
9. Calcium antagonists in heart failure.
Klugmann S; Salvi A; Camerini F
Herz; 1983 Apr; 8(2):88-92. PubMed ID: 6852766
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
11. [Role of calcium antagonists in the pharmacologic treatment of heart insufficiency].
de Sá ME
Rev Port Cardiol; 1989; 8(7-8):547-52. PubMed ID: 2698718
[TBL] [Abstract][Full Text] [Related]
12. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
[TBL] [Abstract][Full Text] [Related]
13. [Ca channel blocker and heart failure].
Kinugawa S; Tsutsui H
Clin Calcium; 2005 Oct; 15(10):1615-22. PubMed ID: 16199906
[TBL] [Abstract][Full Text] [Related]
14. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies].
Gattis W; O'Connor CM
Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855
[TBL] [Abstract][Full Text] [Related]
15. [Calcium antagonists and heart failure. Critical review of the literature].
Devigili G
Minerva Cardioangiol; 1994 Apr; 42(4):177-89. PubMed ID: 8058185
[TBL] [Abstract][Full Text] [Related]
16. Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure.
Metra M; Nodari S; D'Aloia A; Madureri A; Rosselli F; Bontempi L; Zanini R; Dei Cas L
Eur Heart J; 1998 Feb; 19 Suppl B():B25-35. PubMed ID: 9519349
[TBL] [Abstract][Full Text] [Related]
17. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
18. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of heart failure with beta-blockers?].
Osterziel KJ; Dietz R
Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
[TBL] [Abstract][Full Text] [Related]
20. Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction.
Mahé I; Chassany O; Grenard AS; Caulin C; Bergmann JF
Am J Cardiovasc Drugs; 2003; 3(1):33-41. PubMed ID: 14727944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
